MXPA06002778A - Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina. - Google Patents
Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina.Info
- Publication number
- MXPA06002778A MXPA06002778A MXPA06002778A MXPA06002778A MXPA06002778A MX PA06002778 A MXPA06002778 A MX PA06002778A MX PA06002778 A MXPA06002778 A MX PA06002778A MX PA06002778 A MXPA06002778 A MX PA06002778A MX PA06002778 A MXPA06002778 A MX PA06002778A
- Authority
- MX
- Mexico
- Prior art keywords
- reuptake inhibitors
- combination
- norepinephrine
- serotonin
- norepinephrine reuptake
- Prior art date
Links
- 229940127221 norepinephrine reuptake inhibitor Drugs 0.000 title abstract 3
- 239000003772 serotonin uptake inhibitor Substances 0.000 title abstract 2
- 239000003775 serotonin noradrenalin reuptake inhibitor Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical group COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940126570 serotonin reuptake inhibitor Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invencion esta dirigida, en una modalidad, a composiciones farmaceuticas y metodos para tratar depresion en un mamifero, a un mamifero en necesidad de dicho tratamiento se le administran: (i) por lo menos un inhibidor de recaptacion de serotonina o una sal farmaceuticamente aceptable del mismo, y (ii) por lo menos un inhibidor de recaptacion de norepinefrina o una sal farmaceuticamente aceptable del mismo, en donde el inhibidor de recaptacion de norepinefrina se selecciona del grupo formado por la estructura II, la estructura III y la estructura IV, segun se define en la presente.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50127503P | 2003-09-09 | 2003-09-09 | |
| US53889804P | 2004-01-23 | 2004-01-23 | |
| US54069604P | 2004-01-30 | 2004-01-30 | |
| US10/769,018 US20050014848A1 (en) | 2002-01-23 | 2004-01-30 | Combination of serotonin reuptake inhibitors and norephinephrine reuptake inhibitors |
| US10/860,721 US20050009927A1 (en) | 2002-01-23 | 2004-06-03 | Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors |
| PCT/IB2004/002864 WO2005023265A1 (en) | 2003-09-09 | 2004-09-02 | Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA06002778A true MXPA06002778A (es) | 2006-06-14 |
Family
ID=34280166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA06002778A MXPA06002778A (es) | 2003-09-09 | 2004-09-02 | Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1667686A1 (es) |
| BR (1) | BRPI0413726A (es) |
| CA (1) | CA2542339A1 (es) |
| MX (1) | MXPA06002778A (es) |
| NL (1) | NL1026989C2 (es) |
| TW (1) | TW200526197A (es) |
| WO (1) | WO2005023265A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1726039B (zh) | 2002-12-27 | 2010-08-18 | 大塚制药株式会社 | 用于治疗情绪障碍的喹诺酮衍生物和5-羟色胺再摄取抑制剂 |
| AR042806A1 (es) | 2002-12-27 | 2005-07-06 | Otsuka Pharma Co Ltd | Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo |
| AU2005256944A1 (en) * | 2004-06-09 | 2006-01-05 | Pfizer Inc. | Use of reboxetine for the treatment of pain |
| EP3610890A1 (en) | 2012-11-14 | 2020-02-19 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030232805A1 (en) * | 2002-04-24 | 2003-12-18 | Cypress Bioscience, Inc. | Prevention and treatment of functional somatic disorders, including stress-related disorders |
-
2004
- 2004-09-02 CA CA002542339A patent/CA2542339A1/en not_active Abandoned
- 2004-09-02 BR BRPI0413726-4A patent/BRPI0413726A/pt not_active IP Right Cessation
- 2004-09-02 WO PCT/IB2004/002864 patent/WO2005023265A1/en not_active Application Discontinuation
- 2004-09-02 EP EP04769269A patent/EP1667686A1/en not_active Withdrawn
- 2004-09-02 MX MXPA06002778A patent/MXPA06002778A/es not_active Application Discontinuation
- 2004-09-08 NL NL1026989A patent/NL1026989C2/nl not_active IP Right Cessation
- 2004-09-08 TW TW093127197A patent/TW200526197A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1667686A1 (en) | 2006-06-14 |
| BRPI0413726A (pt) | 2006-11-07 |
| WO2005023265A1 (en) | 2005-03-17 |
| CA2542339A1 (en) | 2005-03-17 |
| TW200526197A (en) | 2005-08-16 |
| NL1026989A1 (nl) | 2005-03-10 |
| NL1026989C2 (nl) | 2006-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1933833T3 (da) | Terapi til behandling af overaktiv blære | |
| NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
| RS20050392A (en) | Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor | |
| DE60114994D1 (de) | Blutplättchen-adp-rezeptor-inhibitoren | |
| WO2009155121A3 (en) | Inhibitors of pi3 kinase | |
| UA92000C2 (en) | 1-benzylindole-2-carboxamide derivatives | |
| NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
| NZ598778A (en) | Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions | |
| ATE548034T1 (de) | Pharmazeutische zusammensetzungen mit droxidopa | |
| EA200702282A1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии | |
| GB0112348D0 (en) | Compounds | |
| WO2007024843A3 (en) | Pyrimidinyl-pyrazole inhibitors of aurora kinases | |
| UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
| ZA200806778B (en) | N-Hydroxyacrylamide compounds | |
| DK1370260T3 (da) | Azoler, som malonyl-coa-decarboxylaseinhibitorer anvendelige som mataboliske modulatorer | |
| TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
| WO2007056142A3 (en) | Methods of preventing the serotonin syndrome and compositions for use therefor | |
| IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
| MX2009005798A (es) | Recuperacion de apoplejia. | |
| MXPA06002778A (es) | Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina. | |
| DK1784173T3 (da) | Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater | |
| EA200600998A1 (ru) | Фармацевтическая композиция, содержащая цинк-гиалуронановый комплекс, предназначенная для лечения рассеянного склероза | |
| BR0012502A (pt) | Inibidores da expressão do gene para interleucina 5 | |
| EP1260221A3 (en) | Combination treatment for depression and anxiety |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |